首页> 外文OA文献 >A double-blind randomised controlled trial of a natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer
【2h】

A double-blind randomised controlled trial of a natural oil-based emulsion containing allantoin versus aqueous cream for managing radiation-induced skin reactions in patients with cancer

机译:含尿囊素和水乳膏的天然油基乳剂用于治疗癌症患者放射线引起的皮肤反应的双盲随机对照试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Background:udRadiation-induced skin reaction (RISR) is one of the most common and distressing side effects of radiotherapy in patients with cancer. It is featured with swelling, redness, itching, pain, breaks in skin, discomfort, and a burning sensation. There is a lack of convincing evidence supporting any single practice in the prevention or management of RISR.udMethods/Designs:udThis double-blinded randomised controlled trial aims to investigate the effects of a natural oil-based emulsion containing allantoin (as known as Moogoo Udder Cream®) versus aqueous cream in reducing RISR, improving pain, itching and quality of life in this patient group. One group will receive Moogoo Udder Cream®. Another group will receive aqueous cream. Outcome measures will be collected using patient self-administered questionnaire, interviewer administered questionnaire and clinician assessment at commencement of radiotherapy, weekly during radiotherapy, and four weeks after the completion of radiotherapy.udDiscussion:udDespite advances of radiologic advances and supportive care, RISR are still not well managed. There is a lack of efficacious interventions in managing RISR. While anecdotal evidence suggests that Moogoo Udder Cream® may be effective in managing RISR, research is needed to substantiate this claim. This paper presents the design of a double blind randomised controlled trial that will evaluate the effects of Moogoo Udder Cream® versus aqueous cream for managing in RISR in patients with cancer.udTrial registration: ACTRN 12612000568819
机译:背景:放射诱发的皮肤反应(RISR)是癌症患者放射治疗中最常见且令人困扰的副作用之一。它具有肿胀,发红,发痒,疼痛,皮肤破裂,不适和灼热感的特征。缺乏令人信服的证据支持任何一种预防或管理RISR的方法。 udMethods / Designs: ud这项双盲随机对照试验旨在研究含有尿囊素的天然油基乳剂的作用(称为Moogoo UdderCream®)与水性乳膏相比,在该患者组中降低RISR,改善疼痛,瘙痒和生活质量。一组将获得Moogoo UdderCream®。另一组将接受水性乳膏。在放疗开始时,放疗期间每周以及放疗结束后四个星期,将使用患者自我管理的问卷,访调员管理的问卷和临床医生评估来收集结果指标。 ud讨论: ud尽管放射学和支持治疗有所进步,但RISR仍然管理不善。在管理RISR方面缺乏有效的干预措施。尽管轶事证据表明Moogoo UdderCream®可能在管理RISR方面很有效,但仍需要进行研究以证实这一说法。本文介绍了一项双盲随机对照试验的设计,该试验将评估Moogoo UdderCream®与水性乳膏对癌症患者进行RISR治疗的效果。 ud试验注册:ACTRN 12612000568819

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号